Xantholipin, a novel inhibitor of HSP47 gene expression produced by Streptomyces sp.

Tetrahedron Letters

Volumn 44, Issue 29, 2003, Pages 5427-5430

  Terui, Yuichi ^a   Yiwen, Chu ^b   Jun Ying, Li ^b   Ando, Tsutomu ^a   Yamamoto, Haruaki ^a   Kawamura, Yoji ^a   Tomishima, Yasumitsu ^a   Uchida, Saeko ^a   Okazaki, Tadayasu ^a   Munetomo, Eiji ^a   Seki, Takayuki ^a   Yamamoto, Koji ^a   Murakami, Shigeru ^a   Kawashima, Akira ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

^b Sichuan Industrial Institute of Antibiotics   (China)

Author keywords

HSP47; Xantholipin; Xanthone antibiotics

Indexed keywords

AROMATIC COMPOUND; BACTERIAL PROTEIN; HEAT SHOCK PROTEIN 47; UNCLASSIFIED DRUG; XANTHOLIPIN;

ANALYTIC METHOD; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; GENE EXPRESSION; NONHUMAN; PHYSICAL CHEMISTRY; STREPTOMYCES;

STREPTOMYCES; STREPTOMYCES SP.;

EID: 0037863186     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(03)01318-2     Document Type: Article

References (25)

1. Ang D., Liberek K., Skowyra D., Zylicz M., Georgopoulos G. J. Biol. Chem. 266:1991;24233-24236.
2. Nagata K. Trends Biochem. Sci. 21:1996;23-26.
3. Moriyama T., Kawada N., Ando A., Yamauchi A., Horio M., Nagata K., Imai E., Hori M. Kidney Int. 54:1998;110-119.
4. Sunamoto M., Kuze K., Iehara N., Takeoka H., Nagata K., Kita T., Doi T. Int. J. Exp. Pathol. 79:1998;133-140.
5. Razzaque M.S., Taguchi T. Histol. Histopathol. 14:1999;1199-1212.
6. Masuda H., Fukumoto M., Hirayoshi K., Nagata K. J. Clin. Invest. 94:1994;2481-2488.
7. Razzaque M.S., Taguchi T. J. Pathol. 183:1997;24-29.
8. Sunamoto M., Kuze K., Tsuji H., Ohishi N., Nagata K., Kita T., Doi T. Lab. Invest. 78:1998;967-972.
9. Hirata, H.; Yamamura, I.; Yasuda, K.; Kobayashi, A.; Tada, N.; Suzuki, M.; Hirayoshi, K.; Hosokawa, N.; Nagata, K. J. Biol. Chem. 1999, 274, 35703-35710. HSP47 gene was a gift from Dr. Nagata pRL-SV40 vector (Promega) was used an internal control to detect the basal activity of transcription FireLite (Packard) is a Dual firefly and Renilla luciferase reporter gene assay kit for conducting a luciferase assay.
10. 3 0.2%.
11. 3 0.2%. The pH was adjusted to 7.0.
12. 10K: 590.0256).
13. Drautz H., Keller-Schierlein W., Zahner H. Arch. Microbiol. 106:1975;175-190.
14. Dobler M., Keller-Schierlein W. Helv. Chim. Acta. 60:1977;178-185.
15. Bockholt H., Udvarnoki G., Rohr J. J. Org. Chem. 59:1994;2064-2069.
16. Ohtani I., Kusumi T., Kashman Y., Kakisawa H. J. Am. Chem. Soc. 113:1991;4092-4096.
17. To measure in vitro growth inhibitory activity, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay was used as described previously. Samata, K.; Yamagishi, T.; Ichihara, T.; Nanaumi, K.; Ikeda, T.; Ikeya, H.; Kuraishi, A.; Nakaike, S.; Kashiwagi, K.; Igarashi, K. Cancer Chemother. Pharmacol. 2002, 50, 367-372.
18. Gurevich A.I., Karapetyan M.G., Kolosov M.N., Omelchenko V.N., Onoprienko V.V., Petrenko G.I., Popravko S.A. Tetrahedron Lett. 23:1972;1751-1754.
19. Kobayashi K., Nishino C., Ohya J., Sato S., Mikawa T., Shiobara Y., Kodama M. J. Antibiot. 41:1988;502-511.
20. Kobayashi K., Nishino C., Ohya J., Sato S., Mikawa T., Shiobara Y., Kodama M. J. Antibiot. 41:1988;741-750.
21. Nakagawa A., Iwai Y., Shimizu H., Omura S. J. Antibiot. 39:1986;1636-1638.
22. Nakagawa A., Omura S., Kushida K., Shimizu H., Lukacs G. J. Antibiot. 40:1987;301-308.
23. Tanaka H., Kawakita K., Suzuki H., Spiri-Nakagawa P., Omura S. J. Antibiot. 42:1989;431-439.
24. Carter, G. T.; Nietsche, J. A.; Williams, D. R.; Borders, D. B. Presented at the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles, CA, 23-26 Oct., 1988, Abstract No. 314.
25. Carter G.T., Goodman J.J., Torrey M.J., Borders D.B. J. Org. Chem. 54:1989;4321-4323.